Sign in
Taking people in Hong KongNo phase

Acupuncture for Young People With Psychological Distress and Trouble Sleeping

Tests acupuncture with scalp electrical stimulation in young people with anxiety or low mood.

Key facts

Who runs it
The University of Hong Kong
Where
Hong Kong, Hong KongSee the site
Trial code
Registry title
Clinical Trial for Acupuncture in Adolescents With Psychological Distress and Insomnia
Status
Recruiting
People taking part
148 people, planned
Started
18 Aug 2026
Expected to end
Sept 2028
Type of study
Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
Treatments tested
  • Dense Cranial Electroacupuncture Stimulation plus Body Acupuncture (DCEAS+BA)
  • Minimal Acupuncture Stimulation (MAS)
Record updated
3 November 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for young people aged 15 to 22 with mild to moderate anxiety or depression symptoms. It tests a type of acupuncture with mild electric stimulation of the head, plus body acupuncture.

Age
15 Years to 22 Years
Sex
All
Disease stage
Anxiety with a BAI-C score of at least 8, and/or depression with a C-BDI-II score of at least 14. Symptoms must have lasted more than 3 months. No suicidal thoughts on the C-SSRS questionnaire.
Earlier treatment
No drug treatment for anxiety or depression in the previous 6 months. No acupuncture or brain stimulation in the previous 6 months.

Main reasons for not taking part

  • Unstable serious illness, such as severe liver, heart or kidney disease, cancer, autoimmune disease or acute infection
  • Bipolar disorder or psychotic disorder such as schizophrenia, or epilepsy
  • Past brain injury or brain surgery, or alcohol or drug abuse
  • Pregnant, breastfeeding or planning a pregnancy
  • Pacemaker or other metal implants, bleeding problems, or taking blood thinners

The registry criteria, word for word

Show all 17 criteriaShow less

Who can take part

  • Participants will be eligible for this study if they:
  • are experiencing anxiety as evidenced by a BAI-C score of at least 8 (no symptoms = 0-7; mild = 8-15; moderate = 16-25; severe = 26-63), and/or a C-BDI-II score of at least 14 (no symptoms = 0-13, mild = 14-19; moderate = 20-28; severe = 29-63)
  • have symptoms that have persistent for more than 3 months
  • are able to provide informed consent for participation, and complete treatments and questionnaires as scheduled; and
  • have no suicidal ideation, as evidenced by "no" answers or a score of <3 for all questionnaires of the Columbia-Suicide Severity Rating Scale (C-SSRS)

Who cannot take part

  • have concurrent or use of drug treatment for anxiety/depression in the previous 6 months
  • have treatment with acupuncture or brain stimulation in the previous 6 months
  • have a condition of bleeding tendency, or coagulopathy, or currently receiving anti-coagulant treatment; or
  • have unstable systemic medical conditions that may limit their participation in the study, for example, severe liver, cardiovascular, or kidney impairment; gastrointestinal or endocrine dysfunction; malignancy; autoimmune disease; acute infectious disease; or any conditions with unstable vital signs or require intensive hospitalization
  • have bipolar or psychotic disorder (e.g. schizophrenia)
  • have a history of brain injury or surgery
  • have heart pacemaker or other metal devices implanted in the body
  • have a history of epilepsy
  • involved in other interventional clinical studies in the last 3 months or any relevant condition potentially interfering with study evaluation
  • Participants will be excluded if they:
  • have alcohol abuse or substance abuse
  • are pregnant or in lactation, or intend to conceive

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 15 and 22 years old?

Where in Hong Kong

  • School of Chinese Medicine, University of Hong KongHong Kong, Hong KongContact: Stella Chan Postdoctoral FellowTaking people

About the trial

What the trial wants to find out

This is an assessor-blinded, randomized, MAS-controlled trial. A total of 148 adolescents aged 15-22 years experiencing mild to moderate anxiety or depressive symptoms will be recruited. They will be randomly assigned to DCEAS+BA (n = 74) and MAS (n = 74) for 2 sessions per week for 8 weeks, followed by a 4-week post-treatment observation period. A post-intervention visit will be held at week 12. The primary outcome will be assessed using the Chinese version of the Beck Anxiety Inventory (BAI-C). The secondary outcomes include the Beck Depression Inventory II (C-BDI-II) for depression, the Zung Self-Rating Anxiety Scale (SAS) and the Zung Self-Rating Depression Scale (SDS) as additional assessments for anxiety and depression, the Pittsburgh Sleep Quality Index (PSQI) for sleep quality, and the World Health Organization Quality of Life-Brief (WHOQOL-BREF) (HK version) for the general quality of life. Assessment will be carried out every 4 weeks till week 12, while saliva will be collected at baseline and at the end of the 8 weeks. Salivary oxytocin and cortisol will be analyzed. A generalized linear mixed-effect model will be applied to compare treatment outcomes over time in the two groups and linear regression will be conducted to examine intercorrelations among clinical improvement and changes in biomarker levels. Subgroup analysis will be conducted to identify specific effects of DCEAS+BA.

The 2 groups in the trial

  • DCEAS+BA groupTreatment being tested

    Participants assigned to Dense Cranial Electroacupuncture Stimulation plus Body Acupuncture (DCEAS+BA) group will receive DCEAS+BA treatment, twice weekly for 8 weeks, in addition to their current interventions and medications as usual.

    Treatment: Dense Cranial Electroacupuncture Stimulation plus Body Acupuncture (DCEAS+BA)

  • MAS groupSham treatment, for comparison

    Participants assigned to Minimal Acupuncture Stimulation (MAS) group will receive MAS treatment, twice weekly for 8 weeks, in addition to their current interventions and medications as usual.

    Treatment: Minimal Acupuncture Stimulation (MAS)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Dense Cranial Electroacupuncture Stimulation Plus Body Acupuncture for Adolescents With Psychological Distress: a Randomized Controlled Trial With Observations on Salivary Oxytocin and Cortisol Changes
Plain-language title
Acupuncture for Young People With Psychological Distress and Trouble SleepingGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Fit questions
Built from NCT06638450, who can take part
Record updated
3 November 2026